T. Rowe Price Associates »

Eton Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $436k 18k 24.70
2025-12-31 $260k 15k 16.92
2025-09-30 $294k 14k 21.74
2025-06-30 $183k 13k 14.25
2021-09-30 $122k 24k 5.04
2021-06-30 $1.3M 218k 6.16

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Eton Pharmaceuticals

Opaleye Management
EcoR1 Capital
BlackRock
Nantahala Capital Management
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Oberweis Asset Management
National Philanthropic Trust
Morgan Stanley
Westside Investment Management
Nuveen
Bnp Paribas Arbitrage, Snc
Woodline Partners
Thompson, Siegel, & Walmsley

View all funds holding Eton Pharmaceuticals